Jim Bakken

Jim Bakken

| This email address is being protected from spambots. You need JavaScript enabled to view it.
jimb@uab.edu • (205) 934-3887
Chief Communications Officer, Public Relations 

As chief communications officer for the University of Alabama at Birmingham and UAB Medicine, Bakken leads teams that set and execute internal and external communications strategy. Prior to joining UAB in 2012, Bakken spent a decade working with a diverse client base at two full-service communications firms. Bakken spent eight years in Nashville at McNeely Pigott and Fox – one of the largest PR firms in the Southeast – prior to launching Peritus Public Relations in Birmingham in 2010. Bakken has served on the board of the Plank Center for Leadership in Public Relations, is accredited by the Public Relations Society of America and has been a Birmingham Business Journal Top 40 Under 40 honoree.

Hospital-to-home care transition communications and multimedia programs improving engagement and outcomes for UAB patients.

The ongoing Ebola outbreak in West Africa is the most extensive known outbreak of this disease. While the risk of globalization is low, says one UAB expert, awareness is important.
Investigators from UAB’s Nutrition Obesity Research Center and School of Public Health have been awarded a four-year, $1 million R25 grant to deliver an annual short course on innovative methods to find obesity causes.
With a career spanning more than 40 years, Jack Lemons, Ph.D., is being honored by the School of Public Health for major impacts at UAB.
As kids prepare to go back to school, UAB experts say planning ahead with these tips can help children reach academic and personal goals.
Consuming fried foods and sugar-sweetened beverages is linked to a 50 percent increase in risk of death, according to a new study in the American Journal of Kidney Diseases.
Though kids often stay on track with receiving vaccines due to school requirements, with no system in place, adult rates remain low, according to one UAB expert.
Boni Elewski, M.D., led one of two trials featured in the New England Journal of Medicine that show secukinumab is a safe and effective psoriasis treatment.
The work of Roy Joseph, Ph.D., was chosen as one of the top 3 percent of abstracts submitted at ARVO 2014.
Jessie Dinkel, O.D., has been awarded the Terrance N. Ingraham Pediatric Optometry Residency Award, intended to promote the practice and development of the field.
Page 15 of 173